| Scientific Research Achievements |
Publications:
1.Zou M, Yin X, Zhou X, Niu X, Wang Y, Su M*. Salinomycin-Loaded High-Density Lipoprotein Exerts Promising Anti-Ovarian Cancer Effects by Inhibiting Epithelial-Mesenchymal Transition. Int J Nanomedicine. 2022, 8;17:4059-4071.
2.Zou M#, Su X#, Wang L, Yi X, Qiu Y, Yin X, Zhou X, Niu X, Wang L, Su M*.The Molecular Mechanism of Multiple Organ Dysfunction and Targeted Intervention of COVID-19 Based on Time-Order Transcriptomic Analysis.Front Immunol. 2021,
12:729776. 3.Yin X, Lu Y, Zou M, Wang L, Zhou X, Zhang Y, Su M*.Synthesis and Characterization of Salinomycin-Loaded High-Density Lipoprotein and Its Effects on Cervical Cancer Cells and Cervical Cancer Stem Cells.Int J Nanomedicine. 2021,16:6367-6382.
4.Fu C#, Wang L#, Tian G, Zhang C, Zhao Y, Xu H, Su M*, Wang Y*. Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133+ HepG2 liver cancer cells. Oncology Letters. 2019,17(2):1798-1806.
5.Su M, Wang D, Chang W, Liu L, Cui M*, Xu T*. Preparation of Vitamin E-Containing High-Density Lipoprotein and Its Protective Efficacy on Macrophages.Assay Drug Dev Technol.2018,16(2):107-114.
6.Dong J#, Su M#, Chang W, Zhang K, Wu S, Xu T*.Long non-coding RNAs on the stage of cervical cancer (review).Oncol Rep.2017,38(4):1923-1931
7.Su M, Chang W, Zhang K, Cui M, Wu S, Xu T*.Expression and purification of recombinant ATF-mellitin, a new type fusion protein targeting ovarian cancer cells, in P.pastoris.Oncol Rep.2016, 35(2):1179-85
8.Su M, Chang W, Wang D, Cui M, Lin Y, Wu S, Xu T*.Expression and activity analysis of a new fusion protein targeting ovarian cancer cells.Oncol Rep. 2015,34(3):1337-44
9.Su M, Chang W, Cui M, Lin Y, Wu S, Xu T*.Expression and anticancer activity analysis of recombinant human uPA1-43-melittin.Int J Oncol. 2015, 46(2):619-26
10.Su M, Chang W, Xu T, Cui M, Wu S, Su P. Characteristics of diagnosis and therapy of adolescent malignant ovarian tumors. Eur J Gynaecol Oncol.2014,34(6):565-8
11.Su M, Qi Y, Wang M, Chang W, Peng S, Xu T*, Wang D. Expression and purification of recombinant human apolipoprotein A-II in Pichia pastoris. Assay Drug Dev Technol.2013,11(8):501-507
12.Su M, Chang W, Shi K, Wang D, Wang M, Xu T*, Yan W. Preparation and activity analysis of recombinant human high-density lipoprotein. Assay Drug Dev Technol. 2012,10(5):485-491
13. Su M, Zhou Y, Wang D, Xu T, Chang W, Wang M, Yu X, Feng D, Han Z,Yan W*. Expression and purification of recombinant human apolipoprotein C-I in Pichia pastoris. Protein Expr Purif, 78(1):22-26, 2011 14. Su M, Xu T, Wang D, Zhou Y, Niu C, Yan W*. High yield and purification of recombinant human apolipoprotein E3 in Pichia pastoris. Protein Expr Purif.2009, 68(1):7-11
|
